COMP-05. A DRUG ASSOCIATION MAP OF GLIOBLASTOMA INFORMS PRECISION TARGETING OF p53-DEPENDENT METABOLIC STATES

Glioblastoma (GBM) is a malignant brain tumor with few therapeutic options. Because GBMs are genetically and functionally diverse, there is little systematic understanding of how hundreds of approved drugs may be active against GBM subpopulations. To identify new pharmacological subgroups of GBM, we...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neuro Oncol
Egile Nagusiak: Johansson, Patrik, Almstedt, Elin, Doroszko, Milena, Kundu, Soumi, Vinel, Claire, Lane, David, Nestor, Marika, Marino, Silvia, Krona, Cecilia, Nelander, Sven
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2019
Gaiak:
Computational Omics
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6846896/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.248
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak